Review Article

Targeting Oncogene-Induced Autophagy: A New Approach in Cancer Therapy?

Table 1

Chemical modulators of autophagy and their modes of action.

CompoundMechanismCancer typeRole of autophagyReferences

Inducers of autophagy
AZD8055Inhibits mTORC1 activityNonsmall cell lung cancerProdeath[34]
BortezomibBlocks Bax degradationChronic lymphocytic leukemia Prodeath[35]
BufalinSynergizes with JNK pathway and increases expression of TNF, BECN-1, MAPK, and ATG8Liver cancer
Colorectal cancer
Prodeath
Prodeath
[36]
[37]
ChlorpromazineInhibits PI3K/Akt/mTOR signaling pathwayBrain cancerProdeath[38]
CisplatinActivation of AMPK signaling pathwayLiver cancerProdeath[39]
Compound C (Dorsomorphin)Inhibits AMPK activityColorectal cancerProdeath[40]
EverolimusInhibits mTORC1 activityAcute lymphoblastic leukemia
Prostate cancer
Prodeath
Prodeath
[41]
[42]
FangchinolineTransactivation of sestrin2 gene, leading to AMPK signaling activationLiver cancerProdeath[43]
ImatinibIncreases expression of Beclin-1 and ATG5Chronic myeloid leukemia
Gastrointestinal stromal tumor
Prodeath
Prosurvival
[44]
[45]
NilotinibInduces PP2A-regulated AMPK phosphorylation and activationLiver cancerProdeath[46]
Obatoclax (GX15-070)Induces ATG5-dependent autophagic cell death Acute lymphoblastic leukemiaProdeath[47]
PemetrexedIncreases levels of Akt, p70 S6K, and/or phosphorylated-mTORNonsmall cell lung cancerProdeath[48]
PerifosineInhibits PI3K/Akt/mTOR signaling pathwayChronic myeloid leukemiaProsurvival[49]
PI-103 hydrochlorideInhibits PI3K/Akt/mTOR signaling pathwayBrain cancerProdeath[50]
PP242Inhibits mTORC1 activityMultiple cancersProdeath[51]
ResveratrolAccumulation of intracellular calcium and activation of AMPK/mTOR signaling pathwayNonsmall cell lung cancer Prodeath[52]
SafingolIncreases ROS and/or AMPK activation
Inhibits PKCs and PI3K pathway directly
Breast cancer
Colorectal cancer
Prodeath
Prodeath
[53]
[54]
SalinomycinIncreases ER stress via ATF4-DDIT3/CHOP-TRIB3-Akt-mTOR signaling pathwayNonsmall cell lung cancerProdeath [55]
Sodium seleniteActivates Nrf2
Dephosphorylates PP2A and lead to DAPK activation
Nonsmall cell lung cancer
Promyelocytic leukemia
Prosurvival
Prodeath
[56]
[57]
Sorafenib
SC-59 (Sorafenib derivative)
Inhibits phospho-STAT3 signaling pathway and reduces expression of myeloid cell leukemia (MCL-1), which disrupts Beclin-1-Mcl-1 complexBrain, breast, liver, and lung cancersProdeath
Prodeath
[48]
[58]
STF-62247PI3K signaling pathway and golgi traffickingVHL-deficient renal cancer Prodeath[33]
TemsirolimusInhibits mTORC1 activityMantle cell lymphomaProdeath[59]
Torin-1ATP-competitive mTOR inhibitor that inhibits both mTORC1 and mTORC2 directlyMultiple cancersProdeath[60]
WogoninInhibits p70S6K/Akt pathwayNasopharyngeal cancerProdeath[61]

Inhibitors of autophagy
3-Methyladenine (3-MA)Inhibits PI3K signaling pathwayColorectal cancer
Esophageal cancer
Prosurvival
Prosurvival
[62]
[63]
Bafilomycin A1Prevents fusion of autophagosomes with lysosomes by acting as a V-ATPase inhibitorBreast cancer
Colorectal cancer
Prosurvival
Prosurvival
[64]
[65]
ChloroquineInhibits lysosomal acidification and prevents fusion of autophagosomes with lysosomesBrain cancer
Colorectal cancer
Prosurvival
Prosurvival
[66]
[67]
LucanthoneInduces vacuolization and interferes with lysosomal functionBreast cancerProdeath[68]
Spautin-1Promotes ubiquitylation of Beclin-1Breast cancerProdeath[69]